Novavax (NVAX) Reports Topline Data from Phase 2 Older Adult Trial for RSV F Vaccine Programs; Offers Update on Path Forward
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
Go back to Novavax (NVAX) Reports Topline Data from Phase 2 Older Adult Trial for RSV F Vaccine Programs; Offers Update on Path Forward
July 24, 2017 4:15 PM EDT
Novavax (NASDAQ: NVAX) to Resume Trading at 4:35 PM ET
...
More
July 24, 2017 4:01 PM EDT
Novavax (NASDAQ: NVAX) Halted, News Pending
...
More